251 related articles for article (PubMed ID: 19046960)
1. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension.
Skalska AB; Pietrzycka A; Stepniewski M
Clin Biochem; 2009 Mar; 42(4-5):358-64. PubMed ID: 19046960
[TBL] [Abstract][Full Text] [Related]
2. Relationship between oxidative stress and essential hypertension.
Rodrigo R; Prat H; Passalacqua W; Araya J; Guichard C; Bächler JP
Hypertens Res; 2007 Dec; 30(12):1159-67. PubMed ID: 18344620
[TBL] [Abstract][Full Text] [Related]
3. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension.
Rodrigo R; Prat H; Passalacqua W; Araya J; Bächler JP
Clin Sci (Lond); 2008 May; 114(10):625-34. PubMed ID: 17999638
[TBL] [Abstract][Full Text] [Related]
4. Vascular damage and not hypertension per se influences endothelin-1 plasma levels in patients with non insulin dependent diabetes mellitus.
Perfetto F; Tarquini R; de Leonardis V; Piluso A; Becucci A; Anselmi B; Curradi C; Tapparini L; Tarquini B
Recenti Prog Med; 1997; 88(7-8):317-20. PubMed ID: 9270291
[TBL] [Abstract][Full Text] [Related]
5. Carotid atherosclerosis in elderly hypertensive patients: potential role of endothelin and plasma antioxidant capacity.
Skalska AB; Grodzicki T
J Hum Hypertens; 2010 Aug; 24(8):538-44. PubMed ID: 20016521
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of blood pressure and endothelin-1 plasma concentration in young, hypertensive patients after treatment with angiotensin converting enzyme inhibitor].
Bryl W; Miczke A; Bogdański P; Kujawska-Luczak M; Cymerys M; Pupek-Musialik D; Trojnarska O
Pol Merkur Lekarski; 2005 May; 18(107):524-6. PubMed ID: 16161947
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications.
Merzouk S; Hichami A; Madani S; Merzouk H; Berrouiguet AY; Prost J; Moutairou K; Chabane-Sari N; Khan NA
Gen Physiol Biophys; 2003 Mar; 22(1):15-27. PubMed ID: 12870698
[TBL] [Abstract][Full Text] [Related]
8. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.
Lodovici M; Giovannelli L; Pitozzi V; Bigagli E; Bardini G; Rotella CM
Mutat Res; 2008 Feb; 638(1-2):98-102. PubMed ID: 17964614
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 plasma concentration in children and adolescents with atherogenic risk factors.
Głowińska B; Urban M; Hryniewicz A; Peczyńska J; Florys B; Al-Hwish M
Kardiol Pol; 2004 Oct; 61(10):329-38. PubMed ID: 15841114
[TBL] [Abstract][Full Text] [Related]
10. [Plasma endothelin level in hypertensive patients receiving standard anti-hypertensive therapy with or without statins].
Liu XH; Li YF; Lai CL; Ji YR; Zhao JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):800-3. PubMed ID: 20128377
[TBL] [Abstract][Full Text] [Related]
11. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension.
Simic DV; Mimic-Oka J; Pljesa-Ercegovac M; Savic-Radojevic A; Opacic M; Matic D; Ivanovic B; Simic T
J Hum Hypertens; 2006 Feb; 20(2):149-55. PubMed ID: 16341053
[TBL] [Abstract][Full Text] [Related]
12. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage.
Tse WY; Maxwell SR; Thomason H; Blann A; Thorpe GH; Waite M; Holder R
J Hum Hypertens; 1994 Nov; 8(11):843-9. PubMed ID: 7853328
[TBL] [Abstract][Full Text] [Related]
14. Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics.
Vizza CD; Letizia C; Badagliacca R; Sciomer S; Poscia R; Della Rocca G; Iacoboni C; Leonardo de L; Quattrucci S; Dario C; Luigi P; Fedele F
Regul Pept; 2006 Sep; 136(1-3):85-91. PubMed ID: 16815566
[TBL] [Abstract][Full Text] [Related]
15. [Is hypotensive effectiveness of amlodipine therapy in smokers connected with endothelin-1 (ET-1) concentration?].
Kara-Perz H; Kosicka T; Perz S
Przegl Lek; 2007; 64(10):703-5. PubMed ID: 18409290
[TBL] [Abstract][Full Text] [Related]
16. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes.
Firoozrai M; Nourbakhsh M; Razzaghy-Azar M
Diabetes Res Clin Pract; 2007 Sep; 77(3):427-32. PubMed ID: 17360068
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients.
Cottone S; Mulè G; Guarneri M; Palermo A; Lorito MC; Riccobene R; Arsena R; Vaccaro F; Vadalà A; Nardi E; Cusimano P; Cerasola G
Nephrol Dial Transplant; 2009 Feb; 24(2):497-503. PubMed ID: 18772174
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of assessing coronary flow velocity reserve and plasma endothelin-1 in hypertensive patients.
Fujii H; Takiuchi S; Kamide K; Horio T; Niizuma S; Tanaka N; Hashimoto S; Nakatani S; Fukagawa M; Kawano Y
Hypertens Res; 2005 Nov; 28(11):911-6. PubMed ID: 16555580
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant status in coronary heart disease (CHD) patients with type 2 diabetes mellitus.
Bansilal ; Ali N; Afzal N; Khan TS; Shahjahan S
J Ayub Med Coll Abbottabad; 2007; 19(4):98-101. PubMed ID: 18693610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
